Ke Ding
Impact in
- Organic Chemistry top 0.5%
- Click Chemistry and Applications
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 34
- Cancer therapeutics and mechanisms 34
- Ubiquitin and proteasome pathways 24
- Chemical Synthesis and Analysis 19
- Oncology 84
- HER2/EGFR in Cancer Research 21
- Peptidase Inhibition and Analysis 18
- Co-authors
- Xiaoyun Lu (75 shared papers)Xiaomei Ren (67 shared papers)Zhang Zhang (59 shared papers)Shaomeng Wang (18 shared papers)Jeff B. Smaill (19 shared papers)Qian Cai (13 shared papers)Jingxuan Pan (14 shared papers)Zhengchao Tu (52 shared papers)
- Journals
- Journal of Medicinal Chemistry (59 papers)European Journal of Medicinal Chemistry (25 papers)ACS Medicinal Chemistry Letters (15 papers)Bioorganic & Medicinal Chemistry Letters (15 papers)Journal of the American Chemical Society (8 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Ke Ding
324 papers receiving 10.9k citations
Ke Ding's Hit Papers
Peers
Comparison fields: 5 of 145
- Organic Chemistry 3.7k
- Oncology 2.2k
- Immunology and Allergy 452
- Molecular Biology 5.3k
- Hematology 633
Countries citing papers authored by Ke Ding
This map shows the geographic impact of Ke Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ding more than expected).
Fields of papers citing papers by Ke Ding
This network shows the impact of papers produced by Ke Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ding. The network helps show where Ke Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 338 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction Hit paper breakdown → | 2006 | 607 |
| 2 | Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors Hit paper breakdown → | 2005 | 571 |
| 3 | 2010 | 262 | |
| 4 | 2010 | 199 | |
| 5 | 2010 | 156 | |
| 6 | 2009 | 147 | |
| 7 | 2018 | 137 | |
| 8 | 2016 | 137 | |
| 9 | 2013 | 134 | |
| 10 | 2013 | 132 | |
| 11 | 2013 | 126 | |
| 12 | 2019 | 126 | |
| 13 | 2012 | 126 | |
| 14 | 2020 | 119 | |
| 15 | 2014 | 118 | |
| 16 | 2012 | 113 | |
| 17 | 2013 | 106 | |
| 18 | 2009 | 103 | |
| 19 | 2011 | 102 | |
| 20 | 2010 | 100 |
About Ke Ding
Ke Ding is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Immunology, having authored 338 papers that have together received 11.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (34 papers), Cancer therapeutics and mechanisms (34 papers), Lung Cancer Treatments and Mutations (29 papers), Click Chemistry and Applications (28 papers), Ubiquitin and proteasome pathways (24 papers), HER2/EGFR in Cancer Research (21 papers), Chemical Synthesis and Analysis (19 papers) and Peptidase Inhibition and Analysis (18 papers). The work is most often cited by research in Organic Chemistry (3.7k citations), Oncology (2.2k citations), Immunology and Allergy (452 citations), Molecular Biology (5.3k citations) and Hematology (633 citations). Ke Ding has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xiaoyun Lu, Xiaomei Ren, Zhang Zhang, Shaomeng Wang, Jeff B. Smaill, Qian Cai, Jingxuan Pan, Zhengchao Tu, Zaneta Nikolovska‐Coleska and Zhengqiu Li. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.